A statistical model that takes into account clinical and demographic factors could help guide decisions about treatment in ...

Since 2013, diagnoses of multiple sclerosis (MS) in Finland take less time after symptom onset and treatments follow the ...

Tiziana and Renaissance will partner to accelerate clinical development and potential commercial launch of nasal foralumab.

B-cells were collected from people with and without MS, and those from patients had heightened antibody responses, ...

Interactions between the body's immune system and bacteria that live in the gut become disrupted in multiple sclerosis (MS), ...

Findings from the implanted scaffold led researchers to block specific inflammatory molecules, easing disease severity in a ...

Tired of MS fatigue controlling your life? In the premiere episode of “Get Tough on Multiple Sclerosis,” Dr. Susan Payrovi and Dr. Mirla Avila empower patients to confidently manage their MS ...

Four new SPMS patients not eligible for a Tiziana Life Sciences trial were dosed with foralumab nasal spray in an expanded ...

Columnist Ben Hofmeister explains how songs such as "No One Is to Blame" have become part of the soundtrack of his life with MS.

Tired of MS fatigue controlling your life? In the premiere episode of “Get Tough on Multiple Sclerosis,” Dr. Susan Payrovi ...